La maladie de Parkinson au Canada (serveur d'exploration) - Exploration (Accueil)

Index « Keywords » - entrée « Receptors, Dopamine D3 (metabolism) »
Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.
Receptors, Dopamine D3 (genetics) < Receptors, Dopamine D3 (metabolism) < Receptors, Dopamine D4  Facettes :

List of bibliographic references indexed by Receptors, Dopamine D3 (metabolism)

Number of relevant bibliographic references: 7.
Ident.Authors (with country if any)Title
000398 (2016) Doris E. Payer ; Mark Guttman ; Stephen J. Kish ; Junchao Tong ; John R. Adams ; Pablo Rusjan ; Sylvain Houle ; Yoshiaki Furukawa ; Alan A. Wilson ; Isabelle BoileauD3 dopamine receptor-preferring [11C]PHNO PET imaging in Parkinson patients with dyskinesia
000407 (2016) A Jon Stoessl [Canada]Comment: Increased D3 binding-A substrate for levodopa-induced dyskinesias?
000470 (2015) Doris E. Payer [Canada] ; Mark Guttman ; Stephen J. Kish ; Junchao Tong ; Antonio Strafella ; Martin Zack ; John R. Adams ; Pablo Rusjan ; Sylvain Houle ; Yoshiaki Furukawa ; Alan A. Wilson ; Isabelle Boileau[¹¹C]-(+)-PHNO PET imaging of dopamine D(2/3) receptors in Parkinson's disease with impulse control disorders.
000601 (2015) Philip Seeman [Canada]Parkinson's disease treatment may cause impulse-control disorder via dopamine D3 receptors.
001F26 (2009) Isabelle Boileau [Canada, Niger] ; Mark Guttman [Canada] ; Pablo Rusjan [Canada] ; John R. Adams [Canada] ; Sylvain Houle [Canada] ; Junchao Tong [Canada] ; Oleh Hornykiewicz [Autriche] ; Yoshiaki Furukawa [Canada] ; Alan A. Wilson [Canada] ; Shitij Kapur [Canada] ; Stephen J. Kish [Canada]Decreased binding of the D3 dopamine receptor-preferring ligand [11C]-(+)-PHNO in drug-naïve Parkinson's disease
002834 (2006) Michel St-Hilaire [Canada] ; Emmanuelle Bourhis [Canada] ; Daniel Lévesque [Canada] ; Claude Rouillard [Canada]Impaired behavioural and molecular adaptations to dopamine denervation and repeated L‐DOPA treatment in Nur77‐knockout mice
002999 (2005) Philip Seeman [Canada] ; Françoise Ko ; Matth Us Willeit ; Patrick Mccormick ; Nathalie GinovartAntiparkinson concentrations of pramipexole and PHNO occupy dopamine D2(high) and D3(high) receptors.

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Canada/explor/ParkinsonCanadaV1/Data/Main/Exploration
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/KwdEn.i -k "Receptors, Dopamine D3 (metabolism)" 
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/KwdEn.i  \
                -Sk "Receptors, Dopamine D3 (metabolism)" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd 

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Canada
   |area=    ParkinsonCanadaV1
   |flux=    Main
   |étape=   Exploration
   |type=    indexItem
   |index=    KwdEn.i
   |clé=    Receptors, Dopamine D3 (metabolism)
}}

Wicri

This area was generated with Dilib version V0.6.29.
Data generation: Thu May 4 22:20:19 2017. Site generation: Fri Dec 23 23:17:26 2022